SCHEMBL21362710

SCHEMBL21362710

CCc1ccc(Br)c(C(O)c2ccc(Cl)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AOC3 Q16853 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34
MEN1 O00255 2/20 0.33
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP19A1 P11511 1/20 0.33
TRPA1 O75762 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12290947 0.77 TSHR (0.37) CYP2C9CYP2C19TSHRMAPK1ATM
SCHEMBL20157869 0.76 PSEN1 (0.38) TSHRNPSR1TP53MDM2CYP3A4
SCHEMBL18113374 0.76 LMNA (0.45) MAPK1TDP1AKR1C3AKR1C2MEN1
SCHEMBL21362758 0.74 S1PR3 (0.38) MAPK1AOC3BRD4CREBBP
SCHEMBL11290692 0.74 AOC3 (0.39) CYP2C9CYP2C19MAPK1TDP1AOC3
SCHEMBL11857826 0.72 CNR2 (0.39) CYP2C9CYP2C19MAPK1MEN1LMNA
SCHEMBL22867977 0.72 S1PR3 (0.40) TSHRMAPK1ATMTDP1AOC3
SCHEMBL30986731 0.72 TSHR (0.42) CYP2C9CYP2C19TSHRMAPK1ATM
SCHEMBL5377768 0.72 TSHR (0.42) CYP2C9CYP2C19TSHRMAPK1ATM
SCHEMBL30802067 0.72 TSHR (0.42) CYP2C9CYP2C19TSHRMAPK1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed